JOHNSON & JOHNSON (JNJ)
Clinical trial NCT05702034 updates: 1. completion date: 2026-12-09 → 2026-10-15 2. primary completion date: 2026-11-11 → 2026-10-15 3. enrollment: 12532 → 12523 participants
Clinical trial NCT05702034 updates: 1. completion date: 2026-12-09 → 2026-10-15 2. primary completion date: 2026-11-11 → 2026-10-15 3. enrollment: 12532 → 12523 participants
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical